PHAGO - Targeting TREM2 and CD33 of phagocytes for treatment of Alzheimer’s disease

Hodges, Angela (Primary Investigator)
Gee, Tony (Co-Investigator)
Politis, Marios (Co-Investigator)
Turkheimer, Federico (Co-Investigator)
Howes, Oliver (Co-Investigator)

Project: Research

Status	Finished
Effective start/end date	1/11/2016 → 30/04/2022

Collaborative partners

King's College London
University Hospital Bonn (lead)

Funding

Eli Lilly & Co Ltd: £36,000.00
Eli Lilly & Co Ltd: £42,794.35
EC European Commission: £780,500.00